Biosimilars and Pharma Innovations

October 26-27, 2020
Dubai, UAE

Legal Issues and BPCI Act

The legal problems regarding the follow-on-biologics associate degreed biosimilars are one of the foremost aspects that want an open discussion. Before the actual advent of biosimilars to the market legal problems have up in numbers in their biological process stages. Known organizations have filed cases against alternative 2 claims their rights and for other legal allegations related to the product. This track is dedicated to discussion of all such cases that has been argued among the court of law.

By 2002, the authority had approved thirty six new biologics, followed by thirty seven additional in 2003, another forty in 2004 and thirty-nine additional in 2005. By 2006, the leading class of biological treatment, the red corpuscle attention recombinant glycoprotein (EPO), generated $14 billion in sales revenues, or forty p.c quite the popular ancient pharmaceutical, Lipitor. quite three hundred therapeutic antibodies presently are in clinical development and trials, compared to solely thirteen that already are wide accessible because of legal problems.

Be a member and support us

Visit the App Store to see our app.

Follow us

Authorization Policy

By registering for the conference you grant permission to Conference Series LLC Ltd to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.